August 19, 2022

Bionpa

You are Your Only Limit

Fifth Third Bancorp Lowers Position in iShares Biotechnology ETF (NASDAQ:IBB)

3 min read

Fifth Third Bancorp reduce its stake in iShares Biotechnology ETF (NASDAQ:IBBGet Ranking) by 48.1% in the 1st quarter, in accordance to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,352 shares of the money expert services provider’s stock right after selling 20,681 shares throughout the quarter. Fifth 3rd Bancorp’s holdings in iShares Biotechnology ETF ended up worth $2,912,000 as of its most the latest filing with the Securities & Trade Fee.

Many other institutional buyers also a short while ago modified their holdings of IBB. Citigroup Inc. lifted its stake in shares of iShares Biotechnology ETF by 94.2% in the fourth quarter. Citigroup Inc. now owns 1,597,087 shares of the monetary services provider’s stock well worth $243,748,000 right after acquiring an supplemental 774,549 shares for the duration of the past quarter. Mmbg Expenditure Advisors CO. acquired a new stake in shares of iShares Biotechnology ETF for the duration of the fourth quarter valued at approximately $12,978,000. Colony Team LLC greater its posture in shares of iShares Biotechnology ETF by 2,901.9% throughout the fourth quarter. Colony Group LLC now owns 71,386 shares of the fiscal solutions provider’s stock valued at $10,895,000 immediately after acquiring an extra 69,008 shares through the final quarter. Richmond Brothers Inc. purchased a new stake in shares of iShares Biotechnology ETF in the course of the fourth quarter valued at somewhere around $8,682,000. Ultimately, Spinnaker Expense Group LLC purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at around $7,305,000. 63.88% of the inventory is owned by hedge resources and other institutional investors.

Shares of IBB opened at $120.17 on Friday. The stock has a 50 working day relocating typical of $115.05 and a 200 day relocating ordinary of $126.93. iShares Biotechnology ETF has a 12 thirty day period reduced of $104.29 and a 12 month substantial of $177.37.

The organization also not too long ago declared a quarterly dividend, which was paid out on Wednesday, June 15th. Traders of record on Friday, June 10th were offered a dividend of $.031 per share. This represents a $.12 dividend on an annualized foundation and a dividend yield of .10%. The ex-dividend day of this dividend was Thursday, June 9th.

iShares Biotechnology ETF Enterprise Profile (Get Rating)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an trade-traded fund (ETF). The Fund seeks expenditure results that correspond generally to the price tag and yield performance of the NASDAQ Biotechnology Index (the Index). The Index incorporates securities of NASDAQ outlined organizations that are categorised in accordance to the Market Classification Benchmark as possibly biotechnology or prescription drugs, which also meet other eligibility requirements identified by NASDAQ.

See Also

Want to see what other hedge resources are holding IBB? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBBGet Ranking).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)



Acquire Information & Scores for iShares Biotechnology ETF Day-to-day – Enter your email handle down below to obtain a concise every day summary of the most up-to-date news and analysts’ rankings for iShares Biotechnology ETF and relevant companies with MarketBeat.com’s Free day by day electronic mail e-newsletter.

bionpa.com All rights reserved. | Newsphere by AF themes.